MicroRNA-486-5p, which is downregulated in hepatocellular carcinoma, suppresses tumor growth by targeting PIK3R1

FEBS Journal

Volumn 282, Issue 3, 2015, Pages 579-594

  Huang, Xin Ping ^a   Hou, Jin ^b   Shen, Xiao Yun ^a   Huang, Chao Yuan ^a   Zhang, Xue Hui ^a   Xie, Yu An ^a   Luo, Xiao Ling ^a  

^a GUANGXI MEDICAL UNIVERSITY   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

hepatocellular carcinoma; metastasis; microRNA 486 5p; p85 ; phosphatidylinositol 3 kinase

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; MICRORNA; MICRORNA 486 5P; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOTRANSFERASE; PROTEIN KINASE B; PROTEIN PIK3R1; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; MIRN486 MICRORNA, HUMAN; PIK3R1 PROTEIN, HUMAN;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER INHIBITION; CANCER RECURRENCE; CARCINOGENICITY; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; EMBRYO; FEMALE; GENE OVEREXPRESSION; GENE SILENCING; HEPATOCELLULAR CARCINOMA CELL LINE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; LIVER CARCINOGENESIS; LIVER CELL; LIVER CELL CARCINOMA; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; ANIMAL; BAGG ALBINO MOUSE; CELL MOTION; GENETICS; KAPLAN MEIER METHOD; LIVER TUMOR; METABOLISM; NUDE MOUSE; PATHOLOGY; PHYSIOLOGY; TUMOR CELL CULTURE; TUMOR CELL LINE; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; HUMANS; KAPLAN-MEIER ESTIMATE; LIVER NEOPLASMS; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; MICRORNAS; PHOSPHATIDYLINOSITOL 3-KINASE; PHOSPHATIDYLINOSITOL 3-KINASES; TUMOR CELLS, CULTURED;

EID: 84921693751     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/febs.13167     Document Type: Article

References (42)

1. Altekruse SF, McGlynn KA, &, Reichman ME, (2009) Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005. J Clin Oncol 27, 1485-1491.
2. Jemal A, Bray F, Center MM, Ferlay J, Ward E, &, Forman D, (2011) Global cancer statistics. CA Cancer J Clin 61, 69-90.
3. Law PT, &, Wong N, (2011) Emerging roles of microRNA in the intracellular signaling networks of hepatocellular carcinoma. J Gastroenterol Hepatol 26, 437-449.
4. Barshack I, Meiri E, Rosenwald S, Lebanony D, Bronfeld M, Aviel-Ronen S, Rosenblatt K, Polak-Charcon S, Leizerman I, Ezagouri M, et al,. (2010) Differential diagnosis of hepatocellular carcinoma from metastatic tumors in the liver using microRNA expression. Int J Biochem Cell Biol 42, 1355-1362.
5. Budhu A, Jia HL, Forgues M, Liu CG, Goldstein D, Lam A, Zanetti KA, Ye QH, Qin LX, Croce CM, et al,. (2008) Identification of metastasis-related microRNAs in hepatocellular carcinoma. Hepatology 47, 897-907.
6. Kwak MS, Lee JH, Yoon JH, Yu SJ, Cho EJ, Jang ES, Kim YJ, &, Lee HS, (2012) Risk factors, clinical features, and prognosis of the hepatocellular carcinoma with peritoneal metastasis. Dig Dis Sci 57, 813-819.
7. Guo Y, Zhao J, Bi J, Wu Q, Wang X, &, Lai Q, (2012) Heterogeneous nuclear ribonucleoprotein K (hnRNP K) is a tissue biomarker for detection of early hepatocellular carcinoma in patients with cirrhosis. J Hematol Oncol 5, 37.
8. Fabian MR, Sonenberg N, &, Filipowicz W, (2010) Regulation of mRNA translation and stability by microRNAs. Annu Rev Biochem 79, 351-379.
9. Lewis BP, Burge CB, &, Bartel DP, (2005) Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120, 15-20.
10. Fang JH, Zhou HC, Zeng C, Yang J, Liu Y, Huang X, Zhang JP, Guan XY, &, Zhuang SM, (2011) MicroRNA-29b suppresses tumor angiogenesis, invasion, and metastasis by regulating matrix metalloproteinase 2 expression. Hepatology 54, 1729-1740.
11. Gramantieri L, Ferracin M, Fornari F, Veronese A, Sabbioni S, Liu CG, Calin GA, Giovannini C, Ferrazzi E, Grazi GL, et al,. (2007) Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma. Cancer Res 67, 6092-6099.
12. Hou J, Lin L, Zhou W, Wang Z, Ding G, Dong Q, Qin L, Wu X, Zheng Y, Yang Y, et al,. (2011) Identification of miRNomes in human liver and hepatocellular carcinoma reveals miR-199a/b-3p as therapeutic target for hepatocellular carcinoma. Cancer Cell 19, 232-243.
13. Lan FF, Wang H, Chen YC, Chan CY, Ng SS, Li K, Xie D, He ML, Lin MC, &, Kung HF, (2011) Hsa-let-7 g inhibits proliferation of hepatocellular carcinoma cells by downregulation of c-Myc and upregulation of p16(INK4A). Int J Cancer 128, 319-331.
14. Su H, Yang JR, Xu T, Huang J, Xu L, Yuan Y, &, Zhuang SM, (2009) MicroRNA-101, down-regulated in hepatocellular carcinoma, promotes apoptosis and suppresses tumorigenicity. Cancer Res 69, 1135-1142.
15. Zhang J, Yang Y, Yang T, Liu Y, Li A, Fu S, Wu M, Pan Z, &, Zhou W, (2010) microRNA-22, downregulated in hepatocellular carcinoma and correlated with prognosis, suppresses cell proliferation and tumourigenicity. Br J Cancer 103, 1215-1220.
16. Li H, Xie H, Liu W, Hu R, Huang B, Tan YF, Xu K, Sheng ZF, Zhou HD, Wu XP, et al,. (2009) A novel microRNA targeting HDAC5 regulates osteoblast differentiation in mice and contributes to primary osteoporosis in humans. J Clin Invest 119, 3666-3677.
17. Budhu A, Ji J, &, Wang XW, (2010) The clinical potential of microRNAs. J Hematol Oncol 3, 37.
18. Gedaly RA, Angulo P, Hundley J, Daily MF, Chen C, Koch A, &, Evers BM, (2010) PI-103 and sorafenib inhibit hepatocellular carcinoma cell proliferation by blocking Ras-Raf-MAPK and PI3K-AKT-mTOR pathways. Anticancer Res 30, 4951-4958.
19. Chen M, Gu J, Delclos GL, Killary AM, Fan Z, Hildebrandt MA, Chamberlain RM, Grossman HB, Dinney CP, &, Wu X, (2010) Genetic variations of the PI3K-AKT-mTOR pathway and clinical outcome in muscle invasive and metastatic bladder cancer patients. Carcinogenesis 31, 1387-1391.
20. Whittaker S, Marais R, &, Zhu AX, (2010) The role of signaling pathways in the development and treatment of hepatocellular carcinoma. Oncogene 29, 4989-5005.
21. Zhao L, &, Vogt PK, (2008) Class I PI3K in oncogenic cellular transformation. Oncogene 27, 5486-5496.
22. Lang Q, &, Ling C, (2012) MiR-124 suppresses cell proliferation in hepatocellular carcinoma by targeting PIK3CA. Biochem Biophys Res Commun 426, 247-252.
23. Mees ST, Mardin WA, Sielker S, Willscher E, Senninger N, Schleicher C, Colombo-Benkmann M, &, Haier J, (2009) Involvement of CD40 targeting miR-224 and miR-486 on the progression of pancreatic ductal adenocarcinomas. Ann Surg Oncol 16, 2339-2350.
24. Li D, Liu X, Lin L, Hou J, Li N, Wang C, Wang P, Zhang Q, Zhang P, Zhou W, et al,. (2011) MicroRNA-99a inhibits hepatocellular carcinoma growth and correlates with prognosis of patients with hepatocellular carcinoma. J Biol Chem 286, 36677-36685.
25. Delfino KR, Serao NV, Southey BR, &, Rodriguez-Zas SL, (2011) Therapy-, gender- and race-specific microRNA markers, target. Cancer Genomics Proteomics 8, 173-178.
26. Namlos HM, Meza-Zepeda LA, Baroy T, Ostensen IH, Kresse SH, Kuijjer ML, Serra M, Burger H, Cleton-Jansen AM, &, Myklebost O, (2012) Modulation of the osteosarcoma expression phenotype by microRNAs. PLoS One 7, e48086.
27. Shen J, Liu Z, Todd NW, Zhang H, Liao J, Yu L, Guarnera MA, Li R, Cai L, Zhan M, et al,. (2011) Diagnosis of lung cancer in individuals with solitary pulmonary nodules by plasma microRNA biomarkers. BMC Cancer 11, 374.
28. Vosa U, Vooder T, Kolde R, Vilo J, Metspalu A, &, Annilo T, (2013) Meta-analysis of microRNA expression in lung cancer. Int J Cancer 132, 2884-2893.
29. Navon R, Wang H, Steinfeld I, Tsalenko A, Ben-Dor A, &, Yakhini Z, (2009) Novel rank-based statistical methods reveal microRNAs with differential expression in multiple cancer types. PLoS One 4, e8003.
30. Oh HK, Tan AL, Das K, Ooi CH, Deng NT, Tan IB, Beillard E, Lee J, Ramnarayanan K, Rha SY, et al,. (2011) Genomic loss of miR-486 regulates tumor progression and the OLFM4 antiapoptotic factor in gastric cancer. Clin Cancer Res 17, 2657-2667.
31. Wang J, Tian X, Han R, Zhang X, Wang X, Shen H, Xue L, Liu Y, Yan X, Shen J, et al,. (2014) Downregulation of miR-486-5p contributes to tumor progression and metastasis by targeting protumorigenic ARHGAP5 in lung cancer. Oncogene 33, 1181-1189.
32. Borjigin N, Ohno S, Wu W, Tanaka M, Suzuki R, Fujita K, Takanashi M, Oikawa K, Goto T, Motoi T, et al,. (2012) TLS-CHOP represses miR-486 expression, inducing upregulation of a metastasis regulator PAI-1 in human myxoid liposarcoma. Biochem Biophys Res Commun 427, 355-360.
33. Cheung LW, Hennessy BT, Li J, Yu S, Myers AP, Djordjevic B, Lu Y, Stemke-Hale K, Dyer MD, Zhang F, et al,. (2011) High frequency of PIK3R1 and PIK3R2 mutations in endometrial cancer elucidates a novel mechanism for regulation of PTEN protein stability. Cancer Discov 1, 170-185.
34. Jaiswal BS, Janakiraman V, Kljavin NM, Chaudhuri S, Stern HM, Wang W, Kan Z, Dbouk HA, Peters BA, Waring P, et al,. (2009) Somatic mutations in p85alpha promote tumorigenesis through class IA PI3K activation. Cancer Cell 16, 463-474.
35. Sun M, Hillmann P, Hofmann BT, Hart JR, &, Vogt PK, (2010) Cancer-derived mutations in the regulatory subunit p85alpha of phosphoinositide 3-kinase function through the catalytic subunit p110alpha. Proc Natl Acad Sci USA 107, 15547-15552.
36. Urick ME, Rudd ML, Godwin AK, Sgroi D, Merino M, &, Bell DW, (2011) PIK3R1 (p85alpha) is somatically mutated at high frequency in primary endometrial cancer. Cancer Res 71, 4061-4067.
37. Sun Y, Zhao S, Tian H, Xie X, Xiao F, Li K, &, Song Y, (2009) Depletion of PI3K p85α induces cell cycle arrest and apoptosis in colorectal cancer cells. Oncol Rep 22, 1435-1442.
38. Hong M, Wilkes MC, Penheiter SG, Gupta SK, Edens M, &, Leof EB, (2011) Non-Smad transforming growth factor-β signaling regulated by focal adhesion kinase binding the p85 subunit of phosphatidylinositol 3-kinase. J Biol Chem 286, 17841-17850.
39. Chagpar RB, Links PH, Pastor MC, Furber LA, Hawrysh AD, Chamberlain MD, &, Anderson DH, (2010) Direct positive regulation of PTEN by the p85 subunit of phosphatidylinositol 3-kinase. Proc Natl Acad Sci USA 107, 5471-5476.
40. Taniguchi CM, Winnay J, Kondo T, Bronson RT, Guimaraes AR, Aleman JO, Luo J, Stephanopoulos G, Weissleder R, Cantley LC, et al,. (2010) The phosphoinositide 3-kinase regulatory subunit p85alpha can exert tumor suppressor properties through negative regulation of growth factor signaling. Cancer Res 70, 5305-5315.
41. Selbach M, Schwanhausser B, Thierfelder N, Fang Z, Khanin R, &, Rajewsky N, (2008) Widespread changes in protein synthesis induced by microRNAs. Nature 455, 58-63.
42. Hou J, Wang P, Lin L, Liu X, Ma F, An H, Wang Z, &, Cao X, (2009) MicroRNA-146a feedback inhibits RIG-I-dependent Type I IFN production in macrophages by targeting TRAF6, IRAK1, and IRAK2. J Immunol 183, 2150-2158.